Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
606,775
-
Share change
-
+606,509
-
Total reported value
-
$15,589,189
-
Price per share
-
$25.69
-
Number of holders
-
15
-
Value change
-
+$15,582,189
-
Number of buys
-
14
Institutional Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) as of Q4 2023
As of 31 Dec 2023,
GYRE THERAPEUTICS, INC. - COM (GYRE) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
606,775 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Parallax Volatility Advisers, L.P., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, CITIGROUP INC, Qube Research & Technologies Ltd, and Tower Research Capital LLC (TRC).
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.